TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,135.60−0.13%Brent$109.39+0.16%BTC$81,642.47−0.24%ETH$2,395.06−0.42%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,135.60−0.13%Brent$109.39+0.16%BTC$81,642.47−0.24%ETH$2,395.06−0.42%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Viatris Inc · Overview · TradingHolo

Markets › United States › NAS › VTRS

V

Viatris Inc

NAS:VTRSHealthcareNASDAQ:NBISTOXX:EDD24BP

$18.66+2.39%At closeAt close · Sat 17 Oct · ≈ AED 68.51 · Market cap $21.43B · Next earnings Thu 5 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+2.4%

1M

+8.9%

3M

+9.8%

6M

+27.1%

1Y

+86.9%

Why it's moving today

Viatris Receives U.S. FDA Approval For Ryzumvi® For The Treatment Of Presbyopia

Reuters · Sat 17 Oct

✦ This week in three lines

No written digest yet for VTRS. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +3.7%

Valuation

P/E vs sector−6.1× vs −1.7×

Price / Book vs sector1.5× vs 2.0×

Price / Sales vs sector1.5× vs 4.0×

Price / Free cash flow vs sector11.1× vs −1.6×

Forecasts

7 buy6 hold1 sell14 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 86 beats

Dividends

Yield2.6%

Annual payout$0.4800

Payout ratio−16.0%

Next ex-date—

Years of growth0

Latest news

All VTRS news →

REViatris Receives U.S. FDA Approval For Ryzumvi® For The Treatment Of Presbyopia

Reuters · 3 d ago

TRViatris Inc. (VTRS) Wins FDA Approval for RYZUMVI in Presbyopia

TradingView · 3 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$21.43B

P/E−6.1×

Dividend yield2.6%

52-week range$9.92 – $18.67

Avg volume (20d)9,132,654

Shares outstanding1,148,590,000

Beta0.89

Short interest3.7% of float

Next earningsThu 5 Nov

Radar Score

79

Value78

Quality57

Momentum84

Income98

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products,…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%